CHEK2 and hepatocellular carcinoma: The effect of TIM downregulation was mediated via the phosphorylation of checkpoint kinase 2 (CHEK2) and the reduced expression of eukaryotic elongation factor 1A2 (EEF1A2) [120], which is an oncogene that positively correlated with the survival of HCC patients [121, 122].